Skip to main content
. 2012 Mar 17;2(1):1. doi: 10.1007/s13555-012-0001-y

Fig. 1.

Fig. 1

The Delphi process used to identify and rank treatment options for challenging psoriasis case scenarios. *These discussions occurred before the voluntary withdrawal of efalizumab from the US market. In cases in which efalizumab ranked among the top treatment options, it has been eliminated. +Six of the cases are presented in this article